| Literature DB >> 24622163 |
Bradley J MacIntosh1, Walter Swardfager2, David E Crane3, Nipuni Ranepura4, Mahwesh Saleem4, Paul I Oh5, Bojana Stefanovic6, Nathan Herrmann7, Krista L Lanctôt8.
Abstract
PURPOSE: Physical activity is associated with positive effects on the brain but there is a paucity of clinical neuroimaging data in patients with coronary artery disease (CAD), a cardiovascular condition associated with grey matter loss. The purpose of this study was to determine which brain regions are impacted by cardiopulmonary fitness and with the change in fitness after 6 months of exercise-based cardiac rehabilitation.Entities:
Mesh:
Year: 2014 PMID: 24622163 PMCID: PMC3951327 DOI: 10.1371/journal.pone.0091251
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Participant Demographics (BMI = body mass index, DBP = diastolic blood pressure, SBP = systolic blood pressure, CABG = coronary artery bypass graft, MI = myocardial infarction, ASA = acetylsalicylic acid, ACE = angiotensin-converting-enzyme).
| Demographics | Mean±SD or % | |
| Age [years] | 65.0±7.0 | |
| Education [years] | 16.9±3.1 | |
| Marital status [partnered] | 90% | |
| Ethnicity [number, %] | ||
| Caucasian | 27 (87%) | |
| South Asian | 2 (6.5%) | |
| African American/Afro-Caribbean | 2 (6.5%) | |
| Employment status [number, %] | ||
| Employed | 14 (45%) | |
| Not working/retired | 17 (55%) | |
| Vascular risk factors | ||
| BMI [kg/m2] | 27.9±3.8 | |
| Body Fat [%] | 25.7±5.7 | |
| DBP [mmHg] | 73.4±7.9 | |
| SBP [mmHg] | 124.3±15.2 | |
| Hypertension | 40% | |
| History of smoking | 53% | |
| Cardiac history | ||
| Stent | 47% | |
| CABG | 47% | |
| MI | 37% | |
| Concomitant medications | ||
| ASA use | 100% | |
| Statin | 97% | |
| Beta-blocker | 73% | |
| ACE inhibitor | 57% |
Figure 1Mean cardiopulmonary fitness at baseline (N = 30) and after 6 months of exercise intervention (n = 29).
The paired comparison shows a significant session effect (t = 9.6, df = 28, p<0.0001).
Figure 2Voxel-wise analyses for CBF and GM density.
Brain regions shown in color are significantly correlated with baseline VO2Peak after controlling for age and correcting for multiple comparisons. CBF voxels are shown in red; VBM voxels are shown in blue; the region in yellow is the right putamen and found to be overlapping for CBF and GM data.
Brain regions identified by the voxel-wise CBF and grey matter density analyses.
| MNI Coordinates | Baseline VO2Peak model | Change in VO2Peak model | |||||||||||
| Brain Region | # Voxels | X | Y | Z | adj R2 | t-stat | p-value | sig | adj R2 | t-stat | p-value | sig | |
|
| |||||||||||||
| 1 | Putamen, left | 23 | −30 | 9 | 3 | 0.30 | 3.37 | 0.0023 | ** | −0.01 | 0.26 | 0.3999 | |
| 2 | Putamen, right | 16 | 30 | −9 | 9 | 0.24 | 3.14 | 0.0041 | ** | −0.05 | −0.26 | 0.4004 | |
| 3 | Anterior cingulate, left | 12 | −3 | 42 | 24 | 0.34 | 3.65 | 0.0011 | ** | 0.02 | −0.35 | 0.3659 | |
| 4 | Premotor cortex, right | 9 | 51 | 9 | 27 | 0.24 | 2.78 | 0.0097 | ** | 0.03 | 0.61 | 0.2751 | |
| 5 | Postcentral gyrus, left | 8 | −48 | −27 | 42 | 0.42 | 3.42 | 0.0020 | ** | 0.30 | 1.78 | 0.0430 | * |
|
| |||||||||||||
| 1 | Planum temporale, right | 46 | 42 | −15 | −9 | 0.62 | 6.64 | 0.0000 | ** | 0.00 | 0.00 | 0.5000 | |
| 2 | Temporal pole, left | 26 | −33 | 3 | −36 | 0.51 | 5.47 | 0.0000 | ** | 0.00 | 0.66 | 0.2580 | |
| 3 | Hippocampus, right | 22 | 21 | −21 | −12 | 0.54 | 3.99 | 0.0005 | ** | 0.26 | −0.10 | 0.4599 | |
| 4 | Caudate, left | 20 | −15 | −3 | 6 | 0.64 | 4.31 | 0.0002 | ** | 0.40 | 0.94 | 0.1778 | |
| 5 | Putamen, right | 18 | 21 | 18 | −9 | 0.42 | 3.82 | 0.0007 | ** | 0.26 | 2.24 | 0.0170 | * |
| 6 | Hippocampus, right | 12 | 33 | −9 | −24 | 0.60 | 4.35 | 0.0002 | ** | 0.32 | −0.63 | 0.2664 | |
| 7 | Putamen, left | 12 | −30 | −15 | 6 | 0.42 | 4.42 | 0.0001 | ** | 0.00 | −0.12 | 0.4541 | |
The number of voxels and MNI coordinates are listed. These regions were then used in a linear regression model to assess the effect of VO2Peak and change in VO2Peak with age as a covariate. * denotes significant at P = 0.05 on a 1-tailed test and ** denotes 2-tailed test.
Figure 3Scatter plots show MRI findings at baseline versus the change in VO2Peak.
The linear regression analyses for these two regions / measures were significant (P<0.01). The line of best fit is shown with the grey shaded region showing the 95% confidence interval.